Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cancer

Court rejects Trump-era EPA finding that weed killer safe

A federal appeals court has rejected a Trump administration finding that the active ingredient in the weed killer Roundup does not pose a serious health risk and is “not likely” to cause cancer in humans

The Independent UK

Deborah James makes final TV appearance after revealing doctors gave her just days to live

The 40-year-old blogger said she didn't think she would live to see Embarrassing Bodies air on E4 after doctors gave her just days to live after being discharged from hospital last month

Irish Mirror

Emmerdale’s fans slam ‘Dingle bust up’ as Faith reveals she is dying

Faith Dingle has finally told Cain and Chas that her cancer has returned

Leeds Live

From analysis to the latest developments in health,
read the most diverse news in one place.

Workplace culture at Macmillan cancer charity ‘systemically racist’, report finds

Exclusion of disabled also said to be widespread and staff who complained claimed they were bullied amid ‘cover-ups’

The Independent UK

Emmerdale viewers slam 'vile' behaviour after cancer bombshell

Faith revealed her cancer had returned and was terminal, causing an argument

Liverpool Echo

British man takes on 4,000-miles-long cycle along UK coast for Prostate Cancer UK

Gareth Lyon is taking on a 4,000 mile cycle to raise money and awareness for Prostate Cancer UK - and he's being joined by volunteers along the way for legs of his journey

Daily Mirror

BMO Initiates Coverage On This Gene Editing Spearhead

BMO Capital initiated coverage of Intellia Therapeutics Inc (NASDAQ:NTLA) with a Market Perform rating and a $54 target price. The analyst says Intellia's gene-editing platform could potentially deliver transformative therapies. But challenges around the lack of clarity around an IND approval in the U.S., ongoing CRISPR/Cas9 IP litigations with Editas Medicine Inc (NASDAQ:EDIT), and high patient…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

David Tennant's wife Georgia shares experiences after cancer diagnosis

David Tennant's wife Georgia previously opened up about her experience having a cervical screening and then, later, a colposcopy

Daily Mirror

BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock

BMO Capital Markets initiated the coverage on Precision BioSciences Inc (NASDAQ:DTIL) with an Outperform rating and a price target of $7. The analyst said the thesis is based on: The company's proprietary gene-editing platform, whose mechanism is differentiated in a CRISPR-dominated space, offers several advantages. A diversified pipeline. Asymmetric risk/reward skewed to the upside.…

Benzinga

Irish girl's life 'changed forever' after knee injury turned out to be much more sinister

Organiser Edel Moore launched a fundraiser on GoFundMe for the family of 10-year-old Bridget Hynes earlier this month

Irish Mirror

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

NI couple helping fight to find a cure for cancer after devastating terminal diagnosis

“You really don’t know how strong you are until being strong is your only option.”

Belfast Live

Scientists harness light therapy to target and kill cancer cells in world first

Exclusive: experts believe new form of photoimmunotherapy may become fifth major cancer treatment

The Guardian - UK

Kazia Therapeutics' Shares Gain Following FDA Orphan Drug Status For Childhood Brain Cancer Drug

The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Kazia Therapeutics’ (NASDAQ: KZIA) Paxalisib for the treatment of atypical rhabdoid / teratoid tumors (AT/RT), a rare and highly-aggressive childhood brain cancer.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

4,000 women with breast cancer could benefit from new pill taken twice a day

Abemaciclib is a twice-daily pill that is used with hormone therapy

Irish Mirror

Irish medical device could stop hair loss in chemotherapy patients

The device has already been trialled on healthy patients in University Hospital Galway

Manchester Evening News

Kym Marsh gives update on dad's cancer on BBC Morning Live as her mum gets emotional

The former Coronation Street actress was joined by dad Dave and mum Pauline on the BBC One show

Daily Mirror

Kym Marsh reveals terminally ill dad's cancer has spread as he's set to start new treatment

Kym Marsh's father Dave, 77, was diagnosed with incurable prostate cancer after delaying getting a check-up during the pandemic

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program

LAVA Therapeutics N.V. (NASDAQ:LVTX) hosted a clinical update call focused on initial Phase 1/2a data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) at the American Society of Clinical Oncology and European Hematology Association meetings. "Although preliminary, these data support our view of LAVA-051 as a promising candidate…

Wales Online

Back pain and other red flags that could be a sign of cervical cancer

In the UK, 99.8% of cervical cancer cases are preventable

Daily Record

Deborah James makes last TV appearance after doctors gave her just days to live

The 40-year-old cancer campaigner is currently receiving end of life care at her parents, but has defied all expectations as she makes the most out of her final days.

Evening Standard

Deborah James tells of heartbreaking cancer diagnosis on E4’s Embarrassing Bodies

Deborah James has spoken of the heartbreaking moment she received her cancer diagnosis as she continues to receive end of life care.

Tribune News Service

Preventive care may be free, but follow-up diagnostic tests can bring big bills

When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting the test that told her she had breast cancer.

Daily Record

Dumfries man taking on Tough Mudder to raise funds for Breast Cancer Research Aid

Keir Morton will take on the 15 kilometre obstacle course to raise funds for a cause close to his heart

Manchester Evening News

Dame Deborah James makes last TV appearance as she continues 'smashing taboos' during end-of-life care

The podcast host and cancer campaigner appeared on Embarrassing Bodies

1 … 881 882 883 884

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

Macmillan Cancer Support

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.